This consensus statement by the Association of British Clinical Diabetologists and UK Kidney Association provides context and recommendations regarding the use Finerenone in the management of Diabetic Kidney Disease.
EndoBarrier (also known as Duodenal-Jejunal Bypass Liner (DJBL) or RESET®) is a 60cm tube-like liner made from a thin, flexible and durable impermeable polymer. It is inserted by an endoscopy and prevents food that passes through it from contacting the first two feet of small bowel intestine. In clinical trials it leads to weight loss and improved glycaemic control and may become a useful treatment option in the future.
Although we have emerged from the grips of the Covid pandemic, we are all seeing challenging waves of influenza and Strep A related illnesses. We work in an environment of severe workforce constraints and industrial action on a background of financial worries.
Yet, we have had opportunities this year to physically connect with one another in person and to realise how much talent there is within our membership and the diabetes society as a whole.
We are pleased to announce that Professor Ketan Dhatariya will be the new Chair of ABCD, Ketan will take over from Dr Dipesh Patel when he completes his term of office in June 2023.
Read the results of the annual census of Consultants in Diabetes and Endocrinology, done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London.
JBDS-IP is embarking on an ambitious project of identifying the right number of staff to deliver an ideal, ‘state of the art’ inpatient diabetes service in the UK.
They want to try and determine what are the optimal staffing levels for everyone involved in the team and details of what the team does, or should be doing, not just delivering care.
